Private Ocean’s Bio-Rad Laboratories Class A BIO Stock Holding History

Private Ocean’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1	Closed	–	–	542
2022 Q2	$0	Hold	1	–	–	﹤0.01%	488
2022 Q1	$1K	Buy	+1	New	+$603	﹤0.01%	526

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Ocean's BIO Position: Q3 2022 in Review

Private Ocean sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 1 share.

Private Ocean first reported a position in BIO in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 485 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Private Ocean reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Private Ocean sold 1 Bio-Rad Laboratories Class A share in Q3 2022.
Private Ocean first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 2 quarters.
Private Ocean's Bio-Rad Laboratories Class A position peaked at $1K in Q1 2022.
485 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Private Ocean's 13F filing for Q3 2022, filed 24 Oct 2022.